{"id":"https://openalex.org/W1985275153","doi":"https://doi.org/10.1016/0378-4347(89)80031-3","title":"Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma","display_name":"Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W1985275153","doi":"https://doi.org/10.1016/0378-4347(89)80031-3","mag":"1985275153","pmid":"https://pubmed.ncbi.nlm.nih.gov/2576270"},"language":"en","primary_location":{"id":"doi:10.1016/0378-4347(89)80031-3","doi":"https://doi.org/10.1016/0378-4347(89)80031-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0378-4347(89)80031-3","pdf_url":null,"source":{"id":"https://openalex.org/S14366386","display_name":"Journal of Chromatography B Biomedical Sciences and Applications","issn_l":"0378-4347","issn":["0378-4347","1387-2273","1872-812X","1878-5603"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography B: Biomedical Sciences and Applications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107094825","display_name":"Sai Y. Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sai Y. Chang","raw_affiliation_strings":["Burroughs Wellcome Co., Research Triangle Park, NC 27709","Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, NC 27709","institution_ids":[]},{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083318517","display_name":"Frederic R. Nelson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederic R. Nelson","raw_affiliation_strings":["Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110035305","display_name":"John W. A. Findlay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W.A. Findlay","raw_affiliation_strings":["Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111966322","display_name":"Lester C. E. Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.C.E. Taylor","raw_affiliation_strings":["Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Co., Research Triangle Park, NC 27709, U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4111,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.51042701,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"497","issue":null,"first_page":"288","last_page":"295"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.625,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.625,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.3441999852657318,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acrivastine","display_name":"acrivastine","score":1.0},{"id":"https://openalex.org/keywords/human-plasma","display_name":"human plasma","score":0.7990000247955322},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8949999809265137},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.628000020980835},{"id":"https://openalex.org/keywords/gc-ms-method-development","display_name":"GC-MS method development","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.8661435842514038},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7700669765472412},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6982289552688599},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.6688398718833923},{"id":"https://openalex.org/C82706917","wikidata":"https://www.wikidata.org/wiki/Q10251","display_name":"Plasma","level":2,"score":0.44332176446914673},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.4164649546146393},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.049233436584472656},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.03692540526390076},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011863","descriptor_name":"Radioimmunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014311","descriptor_name":"Triprolidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014311","descriptor_name":"Triprolidine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014311","descriptor_name":"Triprolidine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/0378-4347(89)80031-3","doi":"https://doi.org/10.1016/0378-4347(89)80031-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0378-4347(89)80031-3","pdf_url":null,"source":{"id":"https://openalex.org/S14366386","display_name":"Journal of Chromatography B Biomedical Sciences and Applications","issn_l":"0378-4347","issn":["0378-4347","1387-2273","1872-812X","1878-5603"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography B: Biomedical Sciences and Applications","raw_type":"journal-article"},{"id":"pmid:2576270","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2576270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chromatography","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.7246000170707703,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2035033966","https://openalex.org/W2084315659"],"related_works":["https://openalex.org/W2016399004","https://openalex.org/W2350849490","https://openalex.org/W2031797310","https://openalex.org/W2063685762","https://openalex.org/W1984816235","https://openalex.org/W2065385934","https://openalex.org/W2107954130","https://openalex.org/W2059318126","https://openalex.org/W4300563608","https://openalex.org/W303490186"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}